Reaction Details Report a problem with these data
Target
Interleukin-17A
Ligand
BDBM247031
Substrate
n/a
Meas. Tech.
Human TH17 Cytokine Inhibition ELISA Assay
IC50
<10000±n/a nM
Citation
 Gaweco, A; Tilley, J; Blinn, J Sulfonamide retinoic acid receptor-related orphan receptor modulators and uses thereof US Patent  US9701663 Publication Date 7/11/2017 
Target
Name:
Interleukin-17A
Synonyms:
CTLA8 | Cytotoxic T-lymphocyte-associated antigen 8 | IL-17 | IL17 | IL17A | IL17_HUMAN | il-17a
Type:
Enzyme Catalytic Domain
Mol. Mass.:
17511.44
Organism:
Homo sapiens (Human)
Description:
Q16552
Residue:
155
Sequence:
MTPGKTSLVSLLLLLSLEAIVKAGITIPRNPGCPNSEDKNFPRTVMVNLNIHNRNTNTNPKRSSDYYNRSTSPWNLHRNEDPERYPSVIWEAKCRHLGCINADGNVDYHMNSVPIQQEILVLRREPPHCPNSFRLEKILVSVGCTCVTPIVHHVA
  
Inhibitor
Name:
BDBM247031
Synonyms:
1-((1-(2-fluorophenylsulfonyl)piperidin-4-yl)methyl)-5-(1H-pyrazol-4-yl)-1H-indole | US9701663, 40
Type:
Small organic molecule
Emp. Form.:
C23H23FN4O2S
Mol. Mass.:
438.518
SMILES:
Fc1ccccc1S(=O)(=O)N1CCC(Cn2ccc3cc(ccc23)-c2cn[nH]c2)CC1
Structure:
Search PDB for entries with ligand similarity: